Cite
MLA Citation
Frankie A. Holmes et al.. “Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.” European journal of cancer, vol. 184, 2023, pp. 48–59. http://access.bl.uk/ark:/81055/vdc_100183612913.0x000027